Consolidated Statements Of Operations - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2018
Net revenue	$ 5,537	$ 4,950	$ 5,150
Cost of Revenue	1,369	1,322	1,277
Gross profit	4,168	3,628	3,873
Operating expenses:
Research and development	1,559	1,433	1,320
Marketing and sales	631	702	641
General and administrative	506	460	469
Acquisition-related contingent consideration	5	14	0
Amortization of intangibles	22	23	9
Total operating expenses	2,723	2,632	2,439
Operating income	1,445	996	1,434
Interest and other income (expense), net	63	83	15
Income before provision for (benefit from) income taxes	1,508	1,079	1,449
Provision for (benefit from) income taxes	(1,531)	60	406
Net income	$ 3,039	$ 1,019	$ 1,043
Earnings per share:
Basic	$ 10.37	$ 3.36	$ 3.39
Diluted	$ 10.30	$ 3.33	$ 3.34
Number of shares used in computation:
Basic	293	303	308
Diluted	295	306	312